{
    "RADCURE-1678": {
        "question": "Age: 65.9, Sex: Male, ECOG PS: ECOG 0, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Paranasal Sinus, Subsite: Ethmoid Sinus, T: T4b, N: N0, M : M0, Stage: IVB, Path: Adenoid Cystic, HPV: none, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: Yes, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck cancers, including adenoid cystic carcinoma of the paranasal sinuses. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the base of the skull, nasal cavity, paranasal sinuses, and upper cervical spine.\n- The red masked region of interest (ROI) is located anteriorly, likely corresponding to the ethmoid sinus or adjacent paranasal sinus area.\n- The ROI appears to be a soft tissue density mass or lesion, distinct from the surrounding air-filled sinus cavities.\n- There is no obvious bone destruction visible in this slice, but the lesion is sizable and occupies a significant portion of the sinus cavity.\n- No clear evidence of regional lymphadenopathy or distant metastasis is visible in this single slice.\n- The lesion’s location and density are consistent with a tumor in the ethmoid sinus region.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are: [[270, 111, 124, 270, 195, 154], [270, 111, 124, 270, 195, 154]].\n- Both bounding boxes are identical, indicating a single volumetric region of interest.\n- These coordinates correspond to a specific volume within the CT scan, likely encompassing the tumor mass in the ethmoid sinus region.\n- The bounding box covers the same area as the masked ROI, confirming the lesion’s location and extent.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 65.9-year-old male with ECOG performance status 0, indicating good functional status.\n- Non-smoker, which may reduce risk factors for other head and neck cancers.\n- Primary tumor site: Paranasal sinus, specifically the ethmoid sinus.\n- Tumor staging: T4b (advanced local disease with possible invasion of adjacent structures), N0 (no regional lymph node involvement), M0 (no distant metastasis).\n- Stage IVB disease, indicating locally advanced tumor without nodal or distant spread.\n- Pathology: Adenoid cystic carcinoma, a known aggressive tumor with perineural invasion tendencies.\n- HPV negative, which is typical for adenoid cystic carcinoma and does not confer better prognosis as in HPV-positive squamous cell carcinoma.\n- Treatment: Radiation therapy alone, dose 70 Gy in 35 fractions, no chemotherapy.\n- Local control is targeted, no regional or distant treatment planned.\n- No second primary cancer.\n- Contrast-enhanced imaging used, aiding in tumor delineation.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding box data confirm a large, locally advanced adenoid cystic carcinoma in the ethmoid sinus.\n- The tumor is confined locally without nodal or distant spread.\n- The patient’s good performance status and non-smoking history are favorable prognostic factors.\n- Radiation therapy alone at 70 Gy is standard for local control in unresectable or high-risk adenoid cystic carcinoma.\n- Given the T4b stage and aggressive histology, the risk of local recurrence and distant metastasis remains significant.\n- However, absence of nodal and distant disease and good functional status improve survival probability.\n- Overall, the patient has a guarded but potentially favorable outcome with definitive radiation therapy.\n\n('Answer:Alive',)",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate-radiation oncologist": "No",
        "Round 2-Turn 1-ask_gap-radiation oncologist": "Yes.  \nType of expert needed: Head and Neck Surgical Oncologist or Otolaryngologist (ENT surgeon).  \nReason: While my expertise covers radiation therapy planning and dosing, the patient has a T4b adenoid cystic carcinoma of the paranasal sinus, which often requires multidisciplinary evaluation for potential surgical resectability, assessment of local invasion, and consideration of combined modality treatment. Surgical input is essential to determine if resection is feasible or if radiation alone is appropriate. Additionally, input from a diagnostic radiologist could be valuable for detailed imaging interpretation, but the primary gap is surgical expertise.",
        "Round 2-Turn 1-gap_identified-assistant": "- Head and Neck Surgical Oncologist  \n- Otolaryngologist (ENT surgeon)  \n- Diagnostic Radiologist (for detailed imaging interpretation)",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Head and Neck Surgical Oncologist - Your expertise is strictly limited to evaluating surgical options and feasibility for advanced paranasal sinus tumors, including adenoid cystic carcinoma of the ethmoid sinus. - Hierarchy: Head and Neck Surgical Oncologist == Radiation Oncologist  \n2. Otolaryngologist (ENT surgeon) - Your expertise is strictly limited to diagnosis, surgical management, and functional preservation in sinonasal malignancies, particularly adenoid cystic carcinoma. - Hierarchy: Otolaryngologist == Head and Neck Surgical Oncologist == Radiation Oncologist  \n3. Diagnostic Radiologist - Your expertise is strictly limited to detailed imaging interpretation of paranasal sinus tumors, including assessment of local invasion and staging in adenoid cystic carcinoma. - Hierarchy: Diagnostic Radiologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-head and neck surgical oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the base of the skull, nasal cavity, paranasal sinuses, and upper cervical spine.\n- The red masked region of interest (ROI) is located anteriorly, within the paranasal sinus area, likely corresponding to the ethmoid sinus.\n- The ROI appears as a soft tissue density mass, distinct from the surrounding air-filled sinus cavities.\n- There is no obvious bone destruction or skull base erosion visible in this slice, but the lesion is relatively large and occupies a significant portion of the sinus cavity.\n- No evident regional lymphadenopathy or distant metastasis is visible in this single slice.\n- The lesion’s location and density are consistent with a tumor in the ethmoid sinus region.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are: [[270, 111, 124, 270, 195, 154], [270, 111, 124, 270, 195, 154]].\n- Both bounding boxes are identical, indicating a single volumetric region of interest.\n- These coordinates correspond to a specific volume within the CT scan, encompassing the tumor mass in the ethmoid sinus region.\n- The bounding box overlaps precisely with the masked ROI, confirming the lesion’s location and extent.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 65.9-year-old male with ECOG performance status 0, indicating excellent functional status.\n- Non-smoker, which reduces risk factors for other head and neck malignancies.\n- Primary tumor site: Paranasal sinus, specifically the ethmoid sinus.\n- Tumor staging: T4b (advanced local disease with possible invasion of adjacent critical structures), N0 (no regional lymph node involvement), M0 (no distant metastasis).\n- Stage IVB disease, indicating locally advanced tumor without nodal or distant spread.\n- Pathology: Adenoid cystic carcinoma, known for aggressive local invasion and perineural spread.\n- HPV negative, typical for adenoid cystic carcinoma, no prognostic benefit from HPV positivity.\n- Treatment: Radiation therapy alone, dose 70 Gy in 35 fractions, no chemotherapy.\n- Local control targeted; no regional or distant treatment planned.\n- No second primary cancer.\n- Contrast-enhanced imaging used, aiding in tumor delineation.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding box data confirm a large, locally advanced adenoid cystic carcinoma in the ethmoid sinus.\n- The tumor is confined locally without nodal or distant spread.\n- The patient’s good performance status and non-smoking history are favorable prognostic factors.\n- Radiation therapy alone at 70 Gy is standard for local control in unresectable or high-risk adenoid cystic carcinoma.\n- Given the T4b stage and aggressive histology, the risk of local recurrence and distant metastasis remains significant.\n- However, absence of nodal and distant disease and good functional status improve survival probability.\n- Overall, the patient has a guarded but potentially favorable outcome with definitive radiation therapy.\n\n('Answer:Alive',)",
        "Round 2-Turn 1-gap_recruited_assessment-otolaryngologist (ent surgeon)": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the base of the skull, nasal cavity, paranasal sinuses, and upper cervical spine.\n- The masked region of interest (ROI) is located in the anterior cranial base region, likely involving the nasopharynx or adjacent paranasal sinus area.\n- The ROI appears as a soft tissue density mass, distinct from the surrounding air-filled spaces.\n- There is no obvious bone destruction or intracranial extension visible in this slice.\n- No clear evidence of regional lymphadenopathy or distant metastasis is seen in this single slice.\n- The lesion’s location and density suggest a tumor involving the nasopharyngeal or paranasal sinus region.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are: [[270, 111, 124, 270, 195, 154], [270, 111, 124, 270, 195, 154]].\n- Both bounding boxes are identical, indicating a single volumetric region of interest.\n- These coordinates correspond to a specific volume within the CT scan, likely encompassing the tumor mass in the anterior skull base or paranasal sinus region.\n- The bounding box overlaps with the masked ROI, confirming the lesion’s location and extent.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 65.9-year-old male with ECOG performance status 0, indicating good functional status.\n- Non-smoker, which reduces risk factors for other head and neck cancers.\n- Primary tumor site: Paranasal sinus, specifically the ethmoid sinus.\n- Tumor staging: T4b (advanced local disease with possible invasion of adjacent structures), N0 (no regional lymph node involvement), M0 (no distant metastasis).\n- Stage IVB disease, indicating locally advanced tumor without nodal or distant spread.\n- Pathology: Adenoid cystic carcinoma, known for aggressive behavior and perineural invasion.\n- HPV negative, typical for adenoid cystic carcinoma, no prognostic benefit.\n- Treatment: Radiation therapy alone, dose 70 Gy in 35 fractions, no chemotherapy.\n- Local control targeted, no regional or distant treatment planned.\n- No second primary cancer.\n- Contrast-enhanced imaging used, aiding in tumor delineation.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding box data confirm a large, locally advanced adenoid cystic carcinoma in the ethmoid sinus region.\n- The tumor is confined locally without nodal or distant spread.\n- The patient’s good performance status and non-smoking history are favorable prognostic factors.\n- Radiation therapy alone at 70 Gy is standard for local control in unresectable or high-risk adenoid cystic carcinoma.\n- Given the T4b stage and aggressive histology, the risk of local recurrence and distant metastasis remains significant.\n- However, absence of nodal and distant disease and good functional status improve survival probability.\n- Overall, the patient has a guarded but potentially favorable outcome with definitive radiation therapy.\n\n('Answer:Alive',)",
        "Round 2-Turn 1-gap_recruited_assessment-diagnostic radiologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the base of the skull, nasal cavity, paranasal sinuses, and upper cervical spine.\n- The red masked region of interest (ROI) is located anteriorly, occupying a space consistent with the ethmoid sinus or adjacent paranasal sinus area.\n- The ROI appears as a soft tissue density mass, distinct from the surrounding air-filled sinus cavities.\n- There is no obvious bone destruction or erosion visible in this slice, but the lesion is relatively large and occupies a significant portion of the sinus cavity.\n- No clear evidence of regional lymphadenopathy or distant metastasis is visible in this single slice.\n- The lesion’s location and density are consistent with a tumor in the ethmoid sinus region.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are: [[270, 111, 124, 270, 195, 154], [270, 111, 124, 270, 195, 154]].\n- Both bounding boxes are identical, indicating a single volumetric region of interest.\n- These coordinates correspond to a specific volume within the CT scan, likely encompassing the tumor mass in the ethmoid sinus region.\n- The bounding box covers the same area as the masked ROI, confirming the lesion’s location and extent.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 65.9-year-old male with ECOG performance status 0, indicating good functional status.\n- Non-smoker, which reduces risk factors for other head and neck cancers.\n- Primary tumor site: Paranasal sinus, specifically the ethmoid sinus.\n- Tumor staging: T4b (advanced local disease with possible invasion of adjacent structures), N0 (no regional lymph node involvement), M0 (no distant metastasis).\n- Stage IVB disease, indicating locally advanced tumor without nodal or distant spread.\n- Pathology: Adenoid cystic carcinoma, known for aggressive behavior and perineural invasion.\n- HPV negative, typical for adenoid cystic carcinoma, no improved prognosis as seen in HPV-positive squamous cell carcinoma.\n- Treatment: Radiation therapy alone, dose 70 Gy in 35 fractions, no chemotherapy.\n- Local control is targeted, no regional or distant treatment planned.\n- No second primary cancer.\n- Contrast-enhanced imaging used, aiding in tumor delineation.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding box data confirm a large, locally advanced adenoid cystic carcinoma in the ethmoid sinus.\n- The tumor is confined locally without nodal or distant spread.\n- The patient’s good performance status and non-smoking history are favorable prognostic factors.\n- Radiation therapy alone at 70 Gy is standard for local control in unresectable or high-risk adenoid cystic carcinoma.\n- Given the T4b stage and aggressive histology, the risk of local recurrence and distant metastasis remains significant.\n- However, absence of nodal and distant disease and good functional status improve survival probability.\n- Overall, the patient has a guarded but potentially favorable outcome with definitive radiation therapy.\n\n('Answer:Alive',)",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-head and neck surgical oncologist": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-otolaryngologist (ent surgeon)": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-diagnostic radiologist": "No",
        "Round 2-role-comment": "radiation oncologist:alive|head and neck surgical oncologist:alive|otolaryngologist (ent surgeon):alive|diagnostic radiologist:alive",
        "Round 2-num_agents": 4,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer:Alive',)"
    }
}